Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Current Oncology (Toronto, Ont.)|April 26, 2014
Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensusS Couban, L Savoie, Y Abou Mourad, et al.
American Journal of Hematology|November 26, 1997
Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variantsP B Neame, P Soamboonsrup, B Leber, et al.
Acta Endocrinologica|June 1, 1985
Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndromeO D Bruno, M A Rossi, L N Contreras, et al.
Beneficial Microbes|January 30, 2019
Dysbiosis in early sepsis can be modulated by a multispecies probiotic: a randomised controlled pilot trialV Stadlbauer, A Horvath, I Komarova, et al.
Oncogene|June 22, 1999
Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblastsS T Lee, K P Hoeflich, G W Wasfy, et al.
European Journal of Clinical Nutrition|August 9, 2012
The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot studyB Leber, N J Tripolt, D Blattl, et al.
Oncogene|February 3, 2000
Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocatorC Brenner, H Cadiou, H L Vieira, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2000
Mitochondrio-nuclear translocation of AIF in apoptosis and necrosisE Daugas, S A Susin, N Zamzami, et al.
American Journal of Hematology|April 3, 2001
CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoformR Foley, P Soamboonsrup, R F Carter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failedM J Keating, B Cazin, S Coutré, et al.
Pageof 9